It is proposed that PTEN haploinsufficiency may favor the carcinogenetic effect of “non-specific” somatic mutations and/or interact with germline low-penetrance variants, with the specific gene involved influencing the type of tumor eventually developed. This evidence concerns the gene PTEN and neoplasm.